Proarrhythmic Lipid Inflammatory Mediators: Mechanisms in Obesity Arrhythmias
Open Access
- 12 February 2025
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 240 (2) , e70012
Abstract
The prevalence of obesity and associated metabolic disorders such as diabetes is rapidly increasing; therefore, concerns regarding their cardiovascular consequences, including cardiac arrhythmias, are rising. As obesity progresses, the excessively produced lipids accumulate in unconventional areas such as the epicardial adipose tissue (EAT) around the myocardium. Metabolic alterations in obesity contribute to the transformation of these ectopic fat deposits into arrhythmogenic substrates. However, despite advances in therapeutic approaches, particularly in lowering EAT volume and thickness through sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors and glucagon‐like peptide‐1 (GLP‐1) receptor agonists, obese and diabetic patients still suffer from fatal arrhythmias that may lead to sudden cardiac death. Therefore, an investigation into how unappreciated underlying pathways such as lipid mediators contribute to the transformation of adipose tissues into proinflammatory and arrhythmogenic substrates is of significance. Leukotriene B4 (LTB4) is an eicosanoid derived from arachidonic acid and acts as a lipid mediator. LTB4 has recently been identified to be associated with cardiac ion channel modulations and arrhythmogenic conditions in diabetes. LTB4 increases circulatory free fatty acids (FFAs) and has been associated with adipocyte hypertrophy. LTB4 also interferes with insulin signaling pathways, instigating insulin resistance (IR). In addition, LTB4, as a potent chemoattractant, contributes to the mobilization of circulatory immune cells such as monocytes and promotes inflammatory macrophage polarization and macrophage dysfunction. Thus, this review provides a comprehensive overview of LTB4's underlying pathways in obesity; illustrates how these pathways might lead to alterations in cardiac ion channels, currents, and cardiac arrhythmias; and shows how they might pose a therapeutic target for metabolic‐associated arrhythmias.Keywords
This publication has 160 references indexed in Scilit:
- BLT1 and BLT2: the leukotriene B4 receptorsProstaglandins, Leukotrienes and Essential Fatty Acids, 2003
- Monocyte Chemoattractant Protein-1 and 5-Lipoxygenase Products Recruit Leukocytes in Response to Platelet-Activating Factor-Like Lipids in Oxidized Low-Density LipoproteinThe Journal of Immunology, 2002
- β2-Adrenergic Receptor Agonists Increase Intracellular Free Ca2+ Concentration Cycling in Ventricular Cardiomyocytes through p38 and p42/44 MAPK-mediated Cytosolic Phospholipase A2 ActivationJournal of Biological Chemistry, 2001
- Gαi2but Not Gαi3Is Required for Muscarinic Inhibition of Contractility and Calcium Currents in Adult CardiomyocytesCirculation Research, 2000
- Type I and II models of diabetes produce different modifications of K+ currents in rat heart: role of insulinThe Journal of Physiology, 1998
- Protection from obesity-induced insulin resistance in mice lacking TNF-α functionNature, 1997
- Properties and Regulation of Cytosolic Phospholipase A2Journal of Biological Chemistry, 1997
- TNFα receptor expression in rat cardiac myocytes: TNFα inhibition of L‐type Ca2+ current and Ca2+ transientsFEBS Letters, 1995
- Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cellsCardiovascular Research, 1993
- Arachidonic acid incorporation in cardiomyocytes, endothelial cells and fibroblast-like cells isolated from adult rat heartMolecular and Cellular Biochemistry, 1992